These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29055474)

  • 41. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
    J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
    Brody J; Hellmann MA; Marignier R; Lotan I; Stiebel-Kalish H
    J Neuroophthalmol; 2016 Dec; 36(4):356-362. PubMed ID: 27348750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
    Cai W; Tan S; Zhang L; Shan Y; Wang Y; Lin Y; Zhou F; Zhang B; Chen X; Zhou L; Wang Y; Huang X; Men X; Li H; Qiu W; Hu X; Lu Z
    J Neurol Sci; 2016 Jan; 360():88-93. PubMed ID: 26723980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromyelitis optica spectrum disorders with non opticospinal manifestations as initial symptoms: a long-term observational study.
    Li R; Lu D; Li H; Wang Y; Shu Y; Chang Y; Sun X; Lu Z; Qiu W; Yang Z
    BMC Neurol; 2021 Jan; 21(1):35. PubMed ID: 33494708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiology of neuromyelitis optica spectrum disorder].
    Sherman MA; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):5-12. PubMed ID: 34387440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of clinical characteristics and prognosis of neuromyelitis optic spectrum disease complicated with malignant tumor].
    Huang Q; Xu Z; Li R; Wang YG; Shu YQ; Yang Y; Hu XQ; Chu L; Qiu W
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(31):2496-2500. PubMed ID: 30139002
    [No Abstract]   [Full Text] [Related]  

  • 47. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
    Fernández VC; Alonso N; Melamud L; Villa AM
    Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.
    Sánchez Gomar I; Díaz Sánchez M; Uclés Sánchez AJ; Casado Chocán JL; Suárez-Luna N; Ramírez-Lorca R; Villadiego J; Toledo-Aral JJ; Echevarría M
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.
    Bizzoco E; Lolli F; Repice AM; Hakiki B; Falcini M; Barilaro A; Taiuti R; Siracusa G; Amato MP; Biagioli T; Lori S; Moretti M; Vinattieri A; Nencini P; Massacesi L; Matà S
    J Neurol; 2009 Nov; 256(11):1891-8. PubMed ID: 19479168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population.
    Zhang W; Cui L; Zhang Y; Wang W; Wang R; Liu Z; Peng D; Jiao Y; Jiao J
    J Neurol; 2020 Apr; 267(4):1197-1205. PubMed ID: 31932912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromyelitis optica spectrum disorders in Iran.
    Eskandarieh S; Nedjat S; Azimi AR; Moghadasi AN; Sahraian MA
    Mult Scler Relat Disord; 2017 Nov; 18():209-212. PubMed ID: 29141812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early Onset.
    Fragoso YD; Sousa NAC; Saad T; Alves-Leon SV; Pimentel MLV; Goncalves MVM; Stella CV; Diniz DS; Santos GC; Gomes S; Adoni T; Anacleto A; Claudino R; Malfetano FR; Winckler TCD; Damasceno A; Eboni ACB; Farinhas JGD; Mota RSS
    J Child Neurol; 2019 Aug; 34(9):487-490. PubMed ID: 31012355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
    Xie L; Long Y; Yang N; Shan F; Fan Y; Zhong R; Wu L; Yin J; Gao Q; Cong G
    Neuroimmunomodulation; 2015; 22(5):337-41. PubMed ID: 25721331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neuromyelitis optica spectrum disorders: profile of a cohort according to the 2015 diagnostic criteria].
    Uribe-San Martin R; Ciampi E; Galilea A; Sandoval P; Miranda H; Mellado P; Cruz JP; Huete I; Carcamo C
    Rev Neurol; 2017 Sep; 65(5):193-202. PubMed ID: 28849860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
    Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
    Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
    Flanagan EP; Kaufmann TJ; Krecke KN; Aksamit AJ; Pittock SJ; Keegan BM; Giannini C; Weinshenker BG
    Ann Neurol; 2016 Mar; 79(3):437-47. PubMed ID: 26677112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
    Chen C; Xiaobo S; Yuge W; Yaqing S; Ling F; Lisheng P; Zhengqi L; Wei Q
    Neuroimmunomodulation; 2016; 23(3):151-156. PubMed ID: 27603214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.
    Ran Y; Wang L; Zhang F; Ao R; Dong Z; Yu S
    Clin Neurol Neurosurg; 2017 Apr; 155():75-82. PubMed ID: 28282627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.